Anti-ERO1B/ ERO1LB/ Ero1beta functional antibody

Anti-ERO1B/ ERO1LB/ Ero1beta functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ERO1B/ERO1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0186-Ab-1/ GM-Tg-hg-SE0186-Ab-2Anti-Human ERO1B monoclonal antibodyHuman
GM-Tg-rg-SE0186-Ab-1/ GM-Tg-rg-SE0186-Ab-2Anti-Rat ERO1B monoclonal antibodyRat
GM-Tg-mg-SE0186-Ab-1/ GM-Tg-mg-SE0186-Ab-2Anti-Mouse ERO1B monoclonal antibodyMouse
GM-Tg-cynog-SE0186-Ab-1/ GM-Tg-cynog-SE0186-Ab-2Anti-Cynomolgus/ Rhesus macaque ERO1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0186-Ab-1/ GM-Tg-felg-SE0186-Ab-2Anti-Feline ERO1B monoclonal antibodyFeline
GM-Tg-cang-SE0186-Ab-1/ GM-Tg-cang-SE0186-Ab-2Anti-Canine ERO1B monoclonal antibodyCanine
GM-Tg-bovg-SE0186-Ab-1/ GM-Tg-bovg-SE0186-Ab-2Anti-Bovine ERO1B monoclonal antibodyBovine
GM-Tg-equg-SE0186-Ab-1/ GM-Tg-equg-SE0186-Ab-2Anti-Equine ERO1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0186-Ab-1/ GM-Tg-hg-SE0186-Ab-2; GM-Tg-rg-SE0186-Ab-1/ GM-Tg-rg-SE0186-Ab-2;
GM-Tg-mg-SE0186-Ab-1/ GM-Tg-mg-SE0186-Ab-2; GM-Tg-cynog-SE0186-Ab-1/ GM-Tg-cynog-SE0186-Ab-2;
GM-Tg-felg-SE0186-Ab-1/ GM-Tg-felg-SE0186-Ab-2; GM-Tg-cang-SE0186-Ab-1/ GM-Tg-cang-SE0186-Ab-2;
GM-Tg-bovg-SE0186-Ab-1/ GM-Tg-bovg-SE0186-Ab-2; GM-Tg-equg-SE0186-Ab-1/ GM-Tg-equg-SE0186-Ab-2
Products NameAnti-ERO1B monoclonal antibody
Formatmab
Target NameERO1B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ERO1B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0186-Ag-1Recombinant multi-species ERO1B/ ERO1LB/ Ero1beta protein


    Target information

    Target IDGM-SE0186
    Target NameERO1B
    Gene ID56605,67475,364755,710912,488956,101080662,514361,100050567
    Gene Symbol and Synonyms1300013B24Rik,1700065B09Rik,ero1-beta,ERO1B,Ero1beta,ERO1LB,RGD1563548
    Uniprot AccessionQ86YB8
    Uniprot Entry NameERO1B_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000086619
    Target ClassificationN/A

    The target: ERO1B, gene name: ERO1B, also named as ERO1LB, Ero1beta. Enables thiol oxidase activity. Involved in protein folding in endoplasmic reticulum. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.